Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
  • A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
  • A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
  • A61B8/4444—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to the probe
  • A61B8/445—Details of catheter construction
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
  • A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
  • A61M25/0026—Multi-lumen catheters with stationary elements
  • A61M2025/0037—Multi-lumen catheters with stationary elements characterized by lumina being arranged side-by-side
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
  • A61M2025/0042—Microcatheters, cannula or the like having outside diameters around 1 mm or less
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
  • A61M25/06—Body-piercing guide needles or the like
  • A61M25/0662—Guide tubes
  • A61M2025/0681—Systems with catheter and outer tubing, e.g. sheath, sleeve or guide tube

Definitions

• the field of the invention relates to medical devices, and more particularly to an neurovascular intervention device.
• Intraluminal, intracavity, intravascular, and intracardiac treatments and diagnosis of medical conditions utilizing minimally invasive procedures are effective tools in many areas of medical practice. These procedures are typically performed using diagnostic and interventional catheters that are inserted percutaneously into the arterial network and traversed through the vascular system to the site of interest.
• the diagnostic catheter may have imaging capability, typically an ultrasound imaging device, which is used to locate and diagnose a diseased portion of the body, such as a stenosed region of an artery.
• imaging capability typically an ultrasound imaging device, which is used to locate and diagnose a diseased portion of the body, such as a stenosed region of an artery.
• U.S. Patent No. 5,368,035 issued to Hamm et al., the disclosure of which is incorporated herein by reference, describes a catheter having an intravascular ultrasound imaging transducer.
• intravascular imaging method for the neurovasculature.
• the procedure steps for coronary interventions serve as baseline.
• the use of the imaging device alternates with the use of the treatment device, i.e., a clinician would insert the imaging device to diagnose the area of interest, and then remove the imaging device to insert the appropriate treatment device.
• a clinician would insert the imaging device to diagnose the area of interest, and then remove the imaging device to insert the appropriate treatment device.
• Applied to the neurovascular system this may be particularly undesirable due to time considerations in the treatment of strokes and/or intravascular aneurysms.
• embolus may come in two forms, hard plaque or soft thrombus, and different treatments may be used for each.
• soft thrombus drug treatment may be preferred, since it is a more conservative treatment, but such a treatment may be ineffective for hard plaque, which may require more aggressive treatments such as stent placement.
• the ability to make a quick assessment benefits the patient by receiving the most applicable intervention as soon as possible.
• an aneurysm In the case of an aneurysm, the ability to characterize the aneurysm accurately is very important, particularly for embolic coiling procedures.
• the diameter of the neck of the aneurysm, the diameter o ⁇ the aneurysm itself, the density of the sac thrombus, and the patency of the parent artery are all important items of data when planning intervention.
• the ability to determine and/or confirm these items of data real time may provide a factor of safety when planning the required intervention.
• the embolic coils originally chosen for treatment based on angiograms may have to be modified based on findings that the aneurysm neck is larger or smaller than anticipated. Accordingly, an improved intravascular intervention device would be desirable.
• an intravascular intervention device includes a microcatheter configured for intravascular delivery, an imaging wire received within the microcatheter, and a treatment device received within the microcatheter, wherein the imaging wire and the treatment device may be simultaneously advanced.
• the treatment device is configured to perform intravascular intervention.
• the treatment device may be configured to deliver a stent, an embolic coil and/or a thrombolytic agent.
• the intravascular intervention device may image the area of interest while performing the intravascular intervention, thus allowing imaging to take place in real time.
• Fig. Ia is a cross-sectional side view of a microcatheter in accordance with a preferred embodiment of the present invention.
• Fig. Tl is ' a cfoss-secHonal view of a microcatheter in accordance with a preferred embodiment of the present invention.
• Fig. Ic is a cross-sectional view of a microcatheter in accordance with a preferred embodiment of the present invention.
• Fig. 2a is a cross-sectional side view of an imaging wire in accordance with a preferred embodiment of the present invention.
• Fig. 2b is a cross-sectional view of an imaging wire in accordance with a preferred embodiment of the present invention.
• Fig. 3 is a cross-sectional view of an imaging wire in accordance with a preferred embodiment of the present invention.
• Fig. 4 is a diagram of a medical imaging system in accordance with a preferred embodiment of the present invention.
• a microcatheter 100 is shown.
• the microcatheter 100 is constructed to allow navigation into cerebral arteries.
• Such a microcatheter 100 has a size range of up to 0.027 inches.
• An example - of such a microcatheter is described in U.S. Patent No. 4,739,768 to Engelson, which is hereby incorporated by reference in its entirety.
• the microcatheter 100 includes an outer sheath 110 having a lumen that is capable of receiving an imaging wire 120 and a treatment device 150.
• the microcatheter 100 may utilize a guidewire (not shown) to facilitate in advancing the microcatheter 100 to the area of interest.
• a guidewire (not shown) to facilitate in advancing the microcatheter 100 to the area of interest.
• both the imaging wire 120 and the treatment device 150 may be capable of being advanced beyond the distal end of the sheath 110 of the microcatheter 100.
• Fig. Ib which shows a cross-section of a microcatheter 100
• the microcatheter 100 may receive the imaging wire 120 and the treatment device 150 via a single lumen 103.
• Fig. Ic which shows a cross-section of an alternative microcatheter 100
• the microcatheter 100 may receive the imaging wire 120 and the treatment device 150 through a first lumen 102 and a second lumen 104 respectively.
• the imaging wire 120 includes a sheath 121, preferably braided polymer, that is coupled with a floppy tip 124 at the distal end of the sheath 121.
• the sheath 121 includes a lumen that receives an imaging transducer assembly 130 shown in Fig. 2a.
• the imaging wire sheath 121 may be coated with a lubricious coating that enables improved movement within a vessel.
• the imaging sheath 121 preferably includes a puncture hole i " 22 " t ⁇ wards "" the S ⁇ sla ⁇ 'portion of the imaging wire 120, which allows blood pressure to fill the cavity around the imaging element 130 to improve imaging.
• the sheath braid may discontinue for a particular amount of length, thus allowing the imaging transducer to acquire an image with reduced interference.
• the sheath 121 may be withdrawn completely after reaching the desired position, thus leaving the imaging transducer assembly 130 and the floppy tip 124 exposed to the area of interest.
• it may be desirable to coat the assembly 130 with a lubricious and/or thrombolytic agent, such as heparin.
• the sheath 121 may be a thick walled hypotube or partially hollowed rod to allow attachment of the floppy tip 124 and passage of the imaging transducer assembly 130.
• the sheath 121 may include conductive traces that allow the imaging transducer assembly 130 to be electrically coupled with a proximal connector 200 (shown in Fig. 3).
• a thin coating of insulating material may protect the conductive traces.
• the floppy tip 124 may be composed of a layered coil atop a cylindrical wire that is flattened into a ribbon under the coil. Further, the floppy tip 124 may have a proximally extended axial section over which the imaging transducer 130 may translate (not shown).
• the imaging transducer 130 includes a coaxial cable 132, having a center conductor wire 136 and an outer shield wire 134, shown in Fig. 2b.
• a conductive wire having a diameter of approximately 500 microns, is wrapped around the coaxial cable 132, forming a coil, which functions as a drive shaft 138.
• the wire may be a laser cut Nitinol tube, which allows for torquability and flexibility.
• the drive shaft 138 may be composed of coaxial cables wound such that the cables are kept separated, via individual shielding or additional wire, while surrounding a neutral core.
• the drive shaft 138 may be pre-tensioned.
• a stainless steel housing 140 which serves to reinforce the structure of the imaging transducer assembly 130.
• a silver epoxy 142 Surrounding the coaxial cable 132, within the housing 140 is a silver epoxy 142, a conductive material.
• the housing 140 is electrically coupled to the shield wire 134 of the coaxial cable 132 via the epoxy 142.
• an insulating substance e.g., a non- conductive epoxy 144.
• the drive shaft 138 may be printed with one or more conductive traces that allow communication between the imaging transducer 130 and a proximal connector 200 (shown in Fig. 3), which allows the imaging transducer 130 to connect to external circuitry 300 that processes signals, such as imaging and navigational signals, from the imaging transducer 130, such circuits being well known (shown in fig. "" 4) ' . ' " : ⁇ n yefan ⁇ 'tftef alternative configuration, the drive shaft 138 may be composed of an extruded polymer reinforced with a polymer/fiber/metal braid with the coaxial cable 132 extruded within the walls (not shown).
• a layer of piezoelectric crystal (“PZT") 147 On the distal end of the non-conductive epoxy 144 is a layer of piezoelectric crystal ("PZT") 147, "sandwiched" between a conductive acoustic lens 146 and a conductive backing material 148, formed from an acoustically absorbent material (e.g., an epoxy substrate having tungsten particles).
• the acoustic lens 146 is electrically coupled with the center conductor wire 136 of the coaxial cable 132 via a connector 145 that is insulated from the silver epoxy 142 and the backing material 148 by the non-conductive epoxy 144.
• the acoustic lens 146 may be non-circular and/or have a convex surface.
• the backing material 148 is connected to the steel housing 140.
• the imaging transducer assembly 130 may be surrounded by a sonolucent media.
• the sonolucent media may be saline.
• the sheath 121 of the imaging wire 120 may include a puncture hole 122 to allow blood to surround the imaging transducer assembly 130 as well.
• the imaging transducer assembly 130 may be translatable relative to the floppy tip 124. Further, the floppy tip 124 may be detachable, thereby exposing the imaging transducer assembly 130.
• the PZT layer 147 is electrically excited by both the backing material 148 and the acoustic lens 146.
• the backing material 148 receives its charge from the shield wire 134 of the coaxial cable 132 via the silver epoxy 142 and the steel housing 140, and the acoustic lens 146, which may also be silver epoxy, receives its charge from the center conductor wire 136 of the coaxial cable 132 via the connector 145, which may be silver epoxy as well.
• transducer 130 is replaced by a phased array as disclosed in Griffith et al., U.S. Patent No. 4,841,977, which is hereby incorporated by reference in its entirety.
• other imaging devices may be used, instead of, or in addition to imaging transducers, such as light based apparatuses for obtaining images through optical coherence tomography (OCT).
• OCT optical coherence tomography
• image acquisition using OCT is described in Huang et al., "Optical Coherence Tomography," Science, 254, Nov. 22, 1991, pp 1178-1181, which is hereby incorporated by reference in its entirety.
• a type of OCT imaging device, called an optical coherence domain reflectometer (OCDR) is disclosed in Swanson U.S. Pat. No.
• the treatment device 150 delivers treatment to an intravascular area, such as an area with an aneurysm or an embolism.
• the treatment device 150 may deliver drugs, agents, or medical devices such as embolic coils or stents.
• U.S. Patent No. 4,994,069 to Ritchart entitled “Vaso-Occlusion Coil and Method," the entirety of which is hereby incorporated by reference, describes a treatment device that delivers one or more vaso-occlusive coils.

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Health & Medical Sciences (AREA)
• Medical Informatics (AREA)
• Biophysics (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Pathology (AREA)
• Radiology & Medical Imaging (AREA)
• Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• Heart & Thoracic Surgery (AREA)
• Physics & Mathematics (AREA)
• Molecular Biology (AREA)
• Surgery (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Surgical Instruments (AREA)
• Ultra Sonic Daignosis Equipment (AREA)
• Endoscopes (AREA)
• Medicines Containing Plant Substances (AREA)

Priority Applications (5)

Applications Claiming Priority (2)

Publications (1)

Family

ID=36754258

Family Applications (1)

Country Status (8)

Cited By (2)

Families Citing this family (24)

Citations (8)

Family Cites Families (29)

• 2005
  • 2005-04-20 US US11/111,254 patent/US8467854B2/en active Active
• 2006
  • 2006-04-19 DE DE602006007456T patent/DE602006007456D1/de active Active
  • 2006-04-19 AT AT06750801T patent/ATE434460T1/de not_active IP Right Cessation
  • 2006-04-19 WO PCT/US2006/014850 patent/WO2006113856A1/en not_active Ceased
  • 2006-04-19 EP EP06750801A patent/EP1877124B1/en not_active Not-in-force
  • 2006-04-19 CA CA2605382A patent/CA2605382C/en not_active Expired - Fee Related
  • 2006-04-19 ES ES06750801T patent/ES2326915T3/es active Active
  • 2006-04-19 JP JP2008507859A patent/JP2008538521A/ja active Pending

Patent Citations (8)

Also Published As

Similar Documents

Legal Events